Teva to uphold Copaxone patent until May 2015

Singapore: Israel-based Teva Pharmaceuticals has recieved favourable response in England and Wales regarding the validit...

July 31, 2013 | Wednesday | News
Pricing revision to cost Indian pharma $160 mn

Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPP...

June 25, 2013 | Tuesday | Analysis
US antidepressant market slides down by 4%: report

Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired pat...

October 14, 2013 | Monday | Analysis
Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided ...

May 17, 2016 | Tuesday | News
Celgene settles litigation with India's Natco

Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow Internationa...

December 28, 2015 | Monday | News
Self monitoring diabetes market to reach $358 mn

Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...

July 23, 2013 | Tuesday | Analysis
Do India's bad quality drugs end up in Africa?

Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from I...

September 18, 2014 | Thursday | News
Will Japan be able to reduce its generic drug prices?

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...

May 21, 2013 | Tuesday | Analysis
Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...

September 2, 2015 | Wednesday | News
Mylan signs a settlement agreement with OSI Pharma

Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...

July 25, 2013 | Thursday | News
India bans pain killer 36 years after the US did so

New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...

June 28, 2013 | Friday | News
Beximco Pharma enters EU market

Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...

March 14, 2013 | Thursday | News
Glenmark's new generic gets FDA nod

Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...

August 21, 2015 | Friday | News
Amneal pharma to acquire Actavis Australia's generic business

Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...

April 2, 2015 | Thursday | News
ANI pharma, IDT Australia to commercialize US generic drugs

Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...

August 18, 2015 | Tuesday | News
Brickell Biotech-Kaken Pharma to co-develop dermatology drug

Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...

April 5, 2015 | Sunday | News
Lupin scouts for acquisitions across the world

Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...

July 9, 2013 | Tuesday | News
US rheumatoid arthritis market to reach $9.3 bn by 2020'

Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...

April 2, 2015 | Thursday | Analysis